$FLDM News
Last published 5mo ago
- 5mo agoFLDMLABStandard BioTools Corporate UpdateSTANDARD BIOTOOLS INCEarnings Call TranscriptsThank you for joining the Standard BioTools and Treeline Biosciences Merger Announcement Conference call. I would now like to turn the call over to John Graziano, Standard Bio Tools Vice President of Investor Relations.
- 4y agoFLDMStandard BioTools Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireSOUTH SAN FRANCISCO, Calif., April 05, 2022 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (f/k/a Fluidigm Corporation) (NASDAQ:FLDM) today announced, as required by Nasdaq Stock Market Rules, the grant of equity inducement awards to its new executive offi
- 4y agoFLDMLABFluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.GlobeNewswireNew Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022 Appoints New Management Team and Additional Board Members with Significant Experience to Reinvigorate Growth and Enhance Product Portfolio Embarks on New Chapter of Focused Exec
- 4y agoFLDMFluidigm Stockholders Approve $250 Million Strategic Capital InfusionGlobeNewswireSOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that its stockholders have voted to approve all of the proposals related to the previously announced strategic capital infusion from lead
- 4y agoFLDMFluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking GlobalGlobeNewswireCaligan Partners to Vote "FOR" Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 Fluidigm Board to Appoint Frank Witney, a Director Candidate Recommended by Caligan, if Casdin and
- 4y agoFLDMFluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing SolutionGlobeNewswireCompany Urges ALL Stockholders to Vote "FOR" the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is Not Received on April 1 SOUTH SAN FRANCISCO, Calif., March 28, 2022 (GLOBE NEWSWIRE) -- Flui
- 4y agoFLDMFluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022GlobeNewswireSOUTH SAN FRANCISCO, Calif., March 25, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it convened and then adjourned, without conducting any other business, the Company's Special Meeting of Stockholders (the "Special M
- 4y agoFLDMFluidigm Urges Stockholders to Vote "FOR" ALL Proposals Related to $250 Million Strategic Capital Infusion TODAYGlobeNewswireSOUTH SAN FRANCISCO, Calif., March 21, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today urged Fluidigm stockholders to vote "FOR" ALL proposals related to the previously announced strategic capital infusion from leading life sciences i
- 4y agoFLDMLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote "FOR" ALL Proposals Related to $250 Million Strategic Capital InfusionGlobeNewswireSOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glass Lewis") have rec
- 4y agoFLDMFluidigm Announces Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced financial results for the
- 4y agoFLDMFluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell TherapiesGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement
- 4y agoFLDMFluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global InvestorsGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today filed with the U.S. Securities and Exchange Commission (the "SEC") a preliminary proxy statement for a special meeting of stockholders (the "Special
- 4y agoFLDMMILFluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.GlobeNewswireMission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions Dr. Michael Egholm, Former CTO of Danaher Life Sciences, to Assume Role of CEO and Join Board of
- 4y agoFLDMRover Labs Partners with New Jersey Department of Health to Provide Saliva-based COVID-19 Testing to Public SchoolsPR NewswireNEW YORK, Jan. 11, 2022 /PRNewswire/ -- Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based PCR COVID-19 testing to over 200 New Jersey public schools through a testing program with the New Jersey Departme
- 4y agoFLDMFluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021GlobeNewswireFourth quarter preliminary revenue of $38.0 to $38.3 million Full year 2021 preliminary revenue of $130.3 to $130.6 million Base product and service revenue growth of approximately 13% for fourth quarter and 12% for full year as new Biomark OEM and
- 4y agoFLDMMolecular Stethoscope, Inc. establishes new Corporate Headquarters and Research & Development Laboratories in South San Francisco and appoints Gajus Worthington to its Board of DirectorsPR NewswireSOUTH SAN FRANCISCO, Calif., Jan. 4, 2022 /PRNewswire/ -- Molecular Stethoscope, a leading Precision Medicine biotechnology company pioneering the next-generation cf-mRNA Liquid Biopsy, announced today that it has joined Verily Life Sciences ("Verily")
- 4y agoFLDMFluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company's Biomark Platform Detects Omicron Variant of COVID-19GlobeNewswireSOUTH SAN FRANCISCO, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today confirmed that Omicron variant B.1.1
- 5y agoFLDMBiomark X Offers Industry-Leading Advantages in Speed, Throughput, Flexibility and CostGlobeNewswireStreamlines Operations to Reduce Hands-On Time, Accelerate Results Broad Menu of Applications with Automated Workflow Providing Sample-to-Answer Solutions on a Single Platform SOUTH SAN FRANCISCO, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) --
- 5y agoFLDMFluidigm Announces Third Quarter 2021 Financial ResultsGlobeNewswireBoard Undertaking Review of Range of Value-Enhancing Opportunities SOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through
- 5y agoFLDMImaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate CancerGlobeNewswireSOUTH SAN FRANCISCO, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Imaging Mass Cytometr
- 5y agoFLDMFluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial ResultsGlobeNewswireSOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report thir
- 5y agoFLDMFluidigm 2021 IMC Summit Focuses on 'Uncovering Spatial Biology'GlobeNewswireSOUTH SAN FRANCISCO, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for its IMC™
- 5y agoFLDMFluidigm Announces New Co-Marketing Program under Collaboration Agreement with Visiopharm, Offering AI-Based Image Analysis SoftwareGlobeNewswireSOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a new co-marketing program
- 5y agoFLDMQDELJPMABT+11These Are the Stocks to Watch as Covid Enters Its Next PhaseBloomberg
- 5y agoFLDMFluidigm Announces Collaboration Agreement with Karolinska Institutet to Accelerate Customer Adoption of New CyTOF XTGlobeNewswireSOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration agreement
- 5y agoFLDMFluidigm to Participate in the Cantor Virtual Global Healthcare ConferenceGlobeNewswireSOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that Chris Linthwaite, P
- 5y agoFLDMCyTOF and Maxpar Direct Technologies Utilized in Study Characterizing Immune and Inflammatory Responses in Pregnant Women Infected with SARS-CoV-2GlobeNewswireFindings in Nature Communications Provide Insights That May Help Guide Patient Care Research Study Conducted in Collaboration with Fluidigm's Therapeutic Insights Services SOUTH SAN FRANCISCO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Fluidigm Co
- 5y agoFLDMFluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations SummitGlobeNewswireSOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that company management w
- 5y agoFLDMFluidigm Announces Second Quarter 2021 Financial Results with Total Revenue of $31.0 MillionGlobeNewswireBase business rebounds. Promising early reception to 4th generation mass cytometry instrument. Services business achieves quarterly revenue record of $6.6 million. SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (
- 5y agoFLDMUltivue Announces Co-Marketing Agreement with Fluidigm for Biomarker Imaging Solutions for Precision MedicineBusiness WireUltivue, Inc. and Fluidigm Corporation (NASDAQ:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development. Ultivue, a leader
- 5y agoFLDMFluidigm Announces Collaboration Agreement with Imaging CRO ImaBiotech to Increase Biopharma Access to Imaging Mass CytometryGlobeNewswireSOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration and co-mar
- 5y agoFLDMFluidigm Announces Co-Marketing Agreement with Ultivue for Biomarker Imaging Solutions for Precision MedicineGlobeNewswireSOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement w
- 5y agoCSTMFLDMINFITAL+1Thinking about buying stock in Infinity Pharmaceuticals, US Well Services, Constellium, Fluidigm, or TAL Education?PR NewswireNEW YORK, July 28, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INFI, USWS, CSTM, FLDM, and TAL. T
- 5y agoFLDMFluidigm Announces Conference Call and Webcast of Second Quarter 2021 Financial ResultsGlobeNewswireSOUTH SAN FRANCISCO, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report seco
- 5y agoFLDMRover Labs Provides Saliva-based COVID-19 Testing to New York City Public SchoolsPR NewswireNEW YORK, June 17, 2021 /PRNewswire/ -- Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based COVID-19 testing to approximately 50 New York City public schools during a two-month pilot program that began on
- 5y agoFLDMNext-Generation CyTOF XT Redefines Cytometry with Advances in Automation, Throughput, Time to Results and Total Cost of OwnershipGlobeNewswireSOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of CyTOF® XT, d
- 5y agoFLDMImaging Mass Cytometry Utilized by Global Consortium Focused on New Precision Medicine Approaches for Treatment of Rheumatoid ArthritisGlobeNewswireSOUTH SAN FRANCISCO, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has joined the FLAM
- 5y agoFLDMFluidigm to Present at Upcoming Investor ConferencesGlobeNewswireSOUTH SAN FRANCISCO, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company's manageme
- 5y agoFLDMFluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern TimeGlobeNewswireSOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will host a virtual
- 5y agoFLDMFluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year PeriodGlobeNewswireForecasting underlying base business growth of 16–17% supported by new product innovation SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to
- 5y agoFLDMFluidigm Corp. to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 6, 2021 / Fluidigm Corp. (NASDAQ:FLDM) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 5:00 PM Eastern Time. To listen to the event live or access a replay
- 5y agoFLDMData Published in Nature Communications Demonstrate the Power of Fluidigm's CyTOF and Imaging Mass Cytometry Technologies to Transform Cancer Drug Discovery and Enable New Precision Medicine Approaches in Clinical OncologyGlobeNewswireSOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of data th
- 5y agoBNTXFLDMGSKSBFM+2The Need for Comprehensive Diagnostics Remains as Cases Spike Once MorePR NewswireNEW YORK, April 20, 2021 /PRNewswire/ -- The Director of the U.S. National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, and many other experts have warned that rapid reopening and lifting of pandemic restrictions in many states, as w
- 5y agoFLDMFluidigm Announces Conference Call and Webcast of First Quarter 2021 Financial ResultsGlobeNewswireSOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
- 5y agoFLDMHOLXMRNABNTXRecent Surge of Cases Reiterates the Need for Accurate DiagnosticsPR NewswireThe pandemic is still a very real threat as the number of new cases spiked in the United States once again. Data provided by Johns Hopkins University ...
- 5y agoFLDMFluidigm Announces Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewswireFourth Quarter Total Revenue Increased 38 Percent to $44.6 million Fourth Quarter Product and Service Revenue Increased 26 Percent to $40.5 million Full Year Total Revenue Increased 18 Percent to...
- 5y agoFLDMGeorge Mason University Providing COVID-19 Testing with Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay on Biomark HD PlatformGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
- 5y agoFLDMFluidigm Announces Collaboration with Zhejiang PuLuoTing Health Technology Co. Ltd to Market Fluidigm CyTOF Technology to Clinical Labs in ChinaGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
- 5y agoFLDMNIH Sponsored Study at Stanford University School of Medicine to Utilize Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay to Evaluate Immune Responses in Pediatric Patients with COVID-19GlobeNewswireResearchers Seek Insight into Development and Progression of Multisystem Inflammatory Syndrome in Children Study Exemplifies Increasing Use of CyTOF Technology in Clinical Research SOUTH SAN...
- 5y agoFLDMFluidigm to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceGlobeNewswireSOUTH SAN FRANCISCO, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...